drugset / Trial / NCT00367081
Treatment of Cerebral Toxoplasmosis in HIV/AIDS
Phase 4
Completed
30 enrolled
Department of Medical Services Ministry of Public Health of Thailand
Chiang Mai University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Neurological manifestations of Cerebral toxoplasmosis or Toxoplasmic encephalitis (TE) in most advance stage HIV infected patients composed of fever, headache, alteration of consciousness with focal neurological signs/symptoms such as include hemiparesis, cranial nerve palsies, and ataxia. Generalised convulsions, in ¾ of patients. Moreover meningeal irritation sign or herniation sign may be presented as life threatening condition
Timeline
- Start
- 2003-05
- Primary completion
- —
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sulfadiazine | Unknown | 4 g | — |
| Subject | Sulfamethoxazole | Small molecule | 50 mg/kg | Intravenous |
| Subject | Trimethoprim | Small molecule | 10 mg/kg | Intravenous |
| Subject | pyrimethamine | Small molecule | 50 mg | — |
| Subject | pyrimethamine | Small molecule | 100 mg | — |
| Background | leucoverin | Unknown | 25 mg | — |